NDC Active Ingredient Bevacizumab

Active Ingredient Information

What is Bevacizumab?

An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.

What is the usage for Bevacizumab?

This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.

How many products in the NDC database contain Bevacizumab?

The NDC database has 8 products with the active ingredient Bevacizumab. The following table lists all the products that have this active ingredient.

NDC Products with Bevacizumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0315Proprietary Name: Zirabev Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0342Proprietary Name: Zirabev Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-060Proprietary Name: Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-061Proprietary Name: Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
55513-206Proprietary Name: Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
55513-207Proprietary Name: Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
70121-1754Proprietary Name: Alymsys Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
70121-1755Proprietary Name: Alymsys Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
<